Abstract: Embodiments of the present application provide an end cap, a battery cell, a battery and a power consuming device, which relate to the technical field of batteries. The end cap may include a cap body and a groove. The cap body may have a first surface. The groove may be provided in the cap body to form a pressure relief zone in a region of the cap body where the groove is provided. The groove may be recessed from the first surface in a thickness direction of the cap body, and groove side faces of the groove may include corner faces at corners of the groove. Each corner face may be connected to the first surface via a first chamfer face.

Abstract: Battery cell and a device and a method for manufacturing the same, a battery, and a power consumption device are provided. The battery cell includes: a shell; an end cap patch; an end cap patch; an insulating film, including a main body portion and a flanging portion, wherein the flanging portion is provided between the end cap and the end cap patch; and a first glue layer, comprising a first portion and a second portion which are provided continuously. The first portion is provided around the second portion, and the first portion is provided between the flanging portion and the end cap patch. The first portion bonds the flanging portion and the end cap patch. The second portion is provided between the end cap and the end cap patch, and the second portion bonds the end cap and the end cap patch. The first portion is thinner than the second portion.

Abstract: Disclosed are reactive dyes and preparation methods thereof. The reactive dye may be prepared using heterocyclic primary amine as a diazo component, 4,4?-diamino-2,2?-stilbenedisulfonic acid, s-triazine, or ethylenediamine as a bridging group, and a dimonochlortriazine group as an active group. The color-changing compound is covalently bonded into the fiber chemical structure by nucleophilic substitution reaction between monochlorotriazine and the hydroxyl group in a textile structure, and the size of the conjugated system and the range of electron delocalization of the dye are changed by a reversible isomerization reaction of the hydroxyl group adjacent to the diazo group and the diazo group under different pH regulations. Moreover, the dye has a double color changing structure, which improves the capability of the dye combined with —H/—OH. The pH value range that can cause color changes in the dye is effectively expanded to include weak alkali, weak acid or even neutral conditions.

Abstract: Provided are an end cover assembly, a battery cell, a battery, and an electrical apparatus. The end cover assembly is for a battery cell and comprises: an end cover provided with a pressure relief through hole; a pressure relief mechanism connected to the end cover and covering the pressure relief through hole, and configured to be actuated to release the pressure inside the battery cell when the pressure reaches a threshold; and a reinforcing mechanism, located on a side of the end cover facing away from an electrode assembly of the battery cell, and covering at least a part of the pressure relief through hole. The reinforcing mechanism is at least connected to a portion of the end cover at two sides of the pressure relief through hole along a first direction to enhance the strength of the end cover at the pressure relief through hole.

Abstract: The invention provides an anti-C5 humanized monoclonal antibody with low immunogenicity and low ADCC/CDC function and its application. By modifying the amino acid sequence of the framework region of Eculizumab monoclonal antibody, the immunogenicity was reduced, and the antibody was replaced from IgG2 subtype to IgG1 subtype, and a flexible amino acid sequence was inserted between the CDR3 and CH2 regions of the heavy chain of the IgG1 antibody to reduce the immunogenicity. The purpose of ADCC/CDC function is to improve the stability of the antibody and prolong its half-life. The binding affinity of the monoclonal antibody of the invention to human C5 is similar to that of the original Eculizumab antibody, it can specifically block the complement hemolytic activity of C5 and the production of C5a and can be used for the preparation of C5-targeted paroxysmal nocturnal hemoglobinuria and atypical the drug for the treatment of hemolytic uremic syndrome has excellent clinical therapeutic value.

Abstract: A flight control method includes displaying a user interface configured to receive an operation instruction including coordinates of waypoints, generating route data of a route based on the coordinates of the waypoints, sending the route data to an aircraft to instruct the aircraft to execute the route, recording an interruption point during execution of the route by the aircraft, displaying a plurality of candidate starting points including at least one of the interruption point, a last waypoint of the route before the interruption point, a next waypoint of the route after the interruption point, or a user-designated waypoint, in response to a selection instruction, selecting a target starting point from the plurality of candidate starting points, and controlling the aircraft in an interrupted state to fly to the target starting point and resume the execution of the route from the target starting point.

Abstract: A flight control method includes displaying a user interface configured to receive an operation instruction including coordinates of waypoints, generating route data of a route based on the coordinates of the waypoints, sending the route data to an aircraft to instruct the aircraft to execute the route, recording an interruption point during execution of the route by the aircraft, displaying a plurality of candidate starting points including at least one of the interruption point, a last waypoint of the route before the interruption point, a next waypoint of the route after the interruption point, or a user-designated waypoint, in response to a selection instruction, selecting a target starting point from the plurality of candidate starting points, and controlling the aircraft in an interrupted state to fly to the target starting point and resume the execution of the route from the target starting point.

Abstract: A flight control method includes obtaining route data for instructing an aircraft to fly on a route represented by the route data, analyzing the route data according to a preset splitting condition, splitting the route into multiple sub-routes in response to the route data satisfying the preset splitting condition, and determining a to-be-executed sub-route from the multiple sub-routes and transmitting the to-be-executed sub-route to the aircraft.

Abstract: The present invention provides for the generation and maintenance of pluripotent cells by culturing the cells in the presence of an ALK5 inhibitor.

Abstract: A flight control method includes obtaining route data for instructing an aircraft to fly on a route represented by the route data, analyzing the route data according to a preset splitting condition, splitting the route into multiple sub-routes in response to the route data satisfying the preset splitting condition, and determining a to-be-executed sub-route from the multiple sub-routes and transmitting the to-be-executed sub-route to the aircraft.

Abstract: A flight control method includes acquiring, by a smart terminal, data of at least two flight routes. The flight control method also includes associating, by the smart terminal and based on preset information of at least two aircrafts, at least one aircraft with a flight route of the at least two flight routes. The flight control method further includes based on a result of the associating, sending, by the smart terminal, data of the flight route to the associated at least one aircraft.

Abstract: A method for preparing functional edible oil rich in phytosterol esters and diglycerides includes steps of: 1) adding a raw material: adding phytosterol, triglyceride and a molecular sieve into a reactor, wherein a ratio of the phytosterol and the triglyceride is 1:2-1:4, a molecular sieve amount is 50 g/L; heating to 50-60° C. and stirring for 30-60 min, for obtaining a pre-mixture; 2) providing non-aqueous enzymatic transesterification: adding 5-20 g/L lipase into the pre-mixture, adding 100-200 ppm antioxidant, stirring and reacting for 8-12 h with a temperature of 50-60° C. and an atmospheric pressure, stopping heating and naturally cooling to a room temperature; and 3) post-treating: after reaction, removing the lipase and the molecular sieve by centrifugation, for obtaining the functional edible oil. The functional edible oil rich in two nutritional active components is obtained by the one-step method. Products of the present invention do not need separation and purification, and operation is simple.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.

Abstract: The present invention provides for the generation and maintenance of pluripotent cells by culturing the cells in the presence of an ALK5 inhibitor.

Abstract: A method for preparing functional edible oil rich in phytosterol esters and diglycerides includes steps of: 1) adding a raw material: adding phytosterol, triglyceride and a molecular sieve into a reactor, wherein a ratio of the phytosterol and the triglyceride is 1:2-1:4, a molecular sieve amount is 50 g/L; heating to 50-60° C. and stirring for 30-60 min, for obtaining a pre-mixture; 2) providing non-aqueous enzymatic transesterification: adding 5-20 g/L lipase into the pre-mixture, adding 100-200 ppm antioxidant, stirring and reacting for 8-12 h with a temperature of 50-60° C. and an atmospheric pressure, stopping heating and naturally cooling to a room temperature; and 3) post-treating: after reaction, removing the lipase and the molecular sieve by centrifugation, for obtaining the functional edible oil. The functional edible oil rich in two nutritional active components is obtained by the one-step method. Products of the present invention do not need separation and purification, and operation is simple.

Abstract: The present invention provides for the generation and maintenance of pluripotent cells by culturing the cells in the presence of an ALK5 inhibitor.

Abstract: The present invention provides for identification and use of small molecules to induce pluripotency in mammalian cells as well as other methods of inducing pluripotency.